Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
fever and trembling late the day I had it; trembling late the day I had it; So I skipped second shot. Dr has discouraged me starting the two part again; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix and did not receive the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced fever (Verbatim: fever and trembling late the day I had it), tremor (Verbatim: trembling late the day I had it) and incomplete course of vaccination (Verbatim: So I skipped second shot. Dr has discouraged me starting the two part again). The outcome of the fever and tremor were not reported and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the fever and tremor to be related to Shingrix. It was unknown if the company considered the fever and tremor to be related to Shingrix. Additional Information: GSK Receipt Date: 25-MAR-2025 This case was reported by a patient via interactive digital media. The patient had a bad reaction from Shingrix 1st shot and had fever and trembling late the day he/she had it. The patient said nobody warned him/her, so the patient skipped second shot and doctor had discouraged him/her starting the two part again Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.